Skip to content
Primary Menu

Education, Presentation, Publication

Funding & Recognition

Toxicity of Silica Nanoparticles

Semester: Summer 2026


Presentation description

With the rise in nanotechnology and application to the field of pharmaceutics, nanoparticles have shown great promise for use in controlled drug delivery. Due to their natural abundance, versatility and ability to be chemically manipulated, silica nanoparticles offer an encouraging innovative platform in this area. Coating the nanoparticles with poly(ethylene glycol) (PEG) is a commonly used strategy in drug delivery as PEG is a versatile, hydrophilic synthetic polymer, used as a surface treatment to improve stability, solubility, and circulation time. In recent years, studies have shown that the production of anti-PEG antibodies reduces the efficiency of therapeutics treated with PEG. For PEGylated silica nanoparticles to be used for drug delivery, proving their non-toxicity in the body is critical. There are many different types of silica nanoparticles that offer potential clinical application. The various shapes, sizes, chemical treatments of silica nanoparticles elicit differing immunotoxicity. We aim to test the toxicity of several of these nanoparticles, focusing on PEGylation and compare them to PEG liposomes as a clinically validated benchmark.
Presenter Name: Savannah Cochran
Presentation Type: Poster
Presentation Format: In Person
Presentation #6
College: Engineering
School / Department: Biomedical Engineering
Research Mentor: Hamid Ghandehari
Additional Mentor: Priyanka Arunachalam
Time: 8:30 AM
Physical Location or Zoom link:

Dumke